K Bridge Medical launches Rejuran authenticity labels in Australian clinics

K Bridge Medical is rolling out a new authenticity label system for Rejuran in authorised clinics across Australia on July 25, 2026, a move that requires providers to update their inventory receiving workflows to combat parallel-imported and counterfeit products. Under the new system, clinics must integrate specific verification checks upon delivery. This means staff will need to verify the new authenticity labels on arrival, record the specific batch details in their system, and ensure that only authorised stock is cleared for patient use.

The primary benefit of this system is batch traceability, which gives clinics a clear defense if a patient questions product origin or if an adverse event occurs. Parallel imports have been a quiet headache for Australian injectors, creating pricing confusion and undermining manufacturer support. By implementing these labels, the distributor is forcing a standardized verification process that helps protect clinical reputations. To comply and maintain authorised partner status, you will need to brief your clinic team to log these labels as part of your standard intake protocol once shipments with the new packaging begin arriving.

Source: Aesthetic Medical Practitioner, https://aestheticmedicalpractitioner.com.au/news-events/